Advanced search Help
Searching for terms: EXACT: "COVID 19 Resources" in: series
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
Hospital Closed Point-of-Dispensing (POD) Plan Template for Medical Countermeasures
From the Document: "This plan has been created to meet the needs of most hospitals in the Kansas City area. As you know, there are plans for dispensing medical countermeasures that differ somewhat across jurisdictions. This may alter the internal plans and procedures for hospitals (i.e. receipt of SNS [Strategic National Stockpile] assets). Attention has been paid to write the sections of this plan so they apply to most hospitals. You may have more specific information you wish to include in some sections to make the plan more helpful for your organization. All regular text in this plan can be retained, removed or modified as need. This template is meant to assist you in writing a dispensing plan that meets the needs of your organization. Review this plan carefully and modify it as necessary to match your facility's specific needs. Ensure what is written correlates with your Emergency Operations Plan (EOP) and your Memorandum of Agreement (MOA) (or planning) with your local public health department. Choose language that makes sense based on your procedures, roles, etc. For example, the POD [Point of Dispensing] staff positions at your facility may be slightly different than the ones provided here. Update the position names in the plan to correlate with those used at your facility."
Kansas. Department of Health and Environment
2013-07-31
-
MMWR: Morbidity and Mortality Weekly Report, June 14, 2013
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). [It] is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. This issue of MMWR contains the following: "Nationwide Rubella Epidemic -- Japan, 2013"; "Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users"; "Mass Drug Administration for the Elimination of Lymphatic Filariasis -- Port-au-Prince, Haiti, 2011-2012"; "Emergency Department Visits by Patients with Mental Health Disorders -- North Carolina, 2008-2010"; "Influenza Activity -- United States, 2012-13 Season and Composition of the 2013-14 Influenza Vaccine"; "Update: Severe Respiratory Illness Associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) -- Worldwide, 2012-2013"; "Notes from the Field: Outbreak of Poliomyelitis -- Somalia and Kenya, May 2013"; "Announcement: Recommendations Regarding Tobacco Use and Secondhand Smoke Exposure from the Community Preventive Services Task Force"; and "QuickStats: Percentage of Persons Aged
Centers for Disease Control and Prevention (U.S.)
2013-09-06
-
Case-Control Study to Assess Potential Risk Factors Related to Human Illness Caused by Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Version 2
"The novel Coronavirus now known as Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was first detected in a patient living in Saudi Arabia in September of 2012. Since that time, sporadic cases, small clusters, and in large outbreaks have been reported in several countries. While the source of the virus is currently unknown, it is thought to originate in animals. Human-to-human transmission has also been documented on multiple occasions. Although finding the putative animal reservoir is an important step in controlling spread of the virus, a more immediate need is to understand the route and mode of transmission to humans, and the types of exposures that result in infection. Several possibilities exist, including direct contact with an infected animal, which could be either the reservoir species or an intermediate host species; contact with or consumption of unprocessed animal products; contact with the environment where an infected animal has recently been; or consumption of a food or beverage which has been contaminated by animal excreta. All of these have been implicated in other zoonotic infections. Learning the mode of transmission to humans will allow measures to be taken to interrupt transmission. This investigation will provide data to evaluate risk factors for infection by reviewing exposures of known cases and comparing them to rates of exposure in similar uninfected individuals in the general population."
World Health Organization
2013-07-03
-
Foot-and-Mouth Disease (FMD) Response: 'Ready Reference Guide - Quarantine, Movement Control, and Continuity of Business'
"In an FMD [Foot-and-Mouth Disease] outbreak, quarantine, movement control, and continuity of business (managed movement) help to achieve the goals of an FMD response. In particular, these critical activities work to control and contain FMD, striving to eradicate the virus while providing science- and risk-based approaches to facilitate the movement of non-infected animals and non-contaminated animal products to stabilize animal agriculture, the food supply, the economy, and protect public health."
United States. Department of Agriculture
2013-07
-
Enhancing Global Security through Infectious Disease Threat Reduction
"Reducing global threats posed by infectious disease outbreaks -- whether naturally caused or resulting from a deliberate or accidental release -- requires efforts to prevent outbreaks from occurring and, if prevention efforts fail, to mitigate the effects through early detection and rapid response. These global health security activities are operating within an evolving threat landscape. In efforts to reduce the risk of deliberate attacks, the focus has shifted away from state bioweapons programmes to the potential for biological attacks by non-state actors. With regard to naturally caused outbreaks, new and re-emerging infectious diseases -- such as H7N9 and MERS-CoV -- pose an increasing threat and will have an impact on national and global security over the next few years. The emergence and spread of infectious disease results as much from changes in human behaviour -- including lifestyles and land-use patterns, increased trade and travel -- as from mutations in pathogens. To meet these challenges, the public health and security sectors have traditionally worked independently, using different approaches. However, cooperation between them is essential. Reducing global risks posed by infectious disease outbreaks -- whether naturally occurring or deliberately caused -- is a challenging, complex task; the combined expertise of both sectors is necessary to meet this challenge. Moreover, limited available resources must be shared across sectors to support the broad scope of threat reduction activities necessary for strengthening global health security."
Chatham House/Royal Institute of International Affairs
Yassif, Jaime; Lightfoot, N. F. (Nigel F.), 1945-; Santhakumar, Arthy
2013-07
-
MMWR: Morbidity and Mortality Weekly Report, July 12, 2013
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). [It] is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. This issue of MMWR contains the following: "Homicide Rates Among Persons Aged 10-24 Years -- United States, 1981-2010"; "CDC Grand Rounds: Reducing Severe Traumatic Brain Injury in the United States"; "Outbreak of Salmonella Heidelberg Infections Linked to a Single Poultry Producer -- 13 States, 2012-2013"; "Update: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"; "Announcement: Community Preventive Services Task Force Issues 2013 Annual Report to Congress"; "Errata: Vol. 62, No. 23"; "Errata: Vol. 62, No. 25"; and "QuickStats: Age-Adjusted Death Rates from Esophageal Cancer for Persons Aged ≥65 Years, by Race and Sex -- National Vital Statistics System, United States, 1990-2010". Notifiable Diseases and Mortality Tables from this issue can be accessed at the following link [http://www.cdc.gov/mmwr/index2013.html]
Centers for Disease Control and Prevention (U.S.)
2013-08-09
-
Federal Telework: Office of Personnel Management's 2012 Telework Report Shows Opportunities for Improvement
"The Telework Enhancement Act of 2010 requires the Office of Personnel Management (OPM) to submit an annual report to Congress addressing the telework program of each executive agency. The act also required us to review OPM's first report and submit a report to Congress on the progress each executive agency has made towards the goals established under the act. We fulfilled the mandate with a briefing to staff from both committees on our preliminary findings during the first week of May 2013. This report transmits the final briefing slides and includes recommendations we are making to the Acting Director of OPM. See enclosure I for the briefing slides. We assessed the extent to which OPM's '2012 Status of Telework in the Federal Government: Report to the Congress' reported and assessed progress of federal executive agencies' telework participation and outcomes, including societal impacts and cost savings. Separately, we also gathered additional information regarding challenges smaller agencies may have encountered in implementing telework programs."
United States. Government Accountability Office
2013-06-28
-
Updated Rapid Risk Assessment: Severe Respiratory Disease Associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
"[1] As of 17 June 2013, 64 cases of MERS-CoV had been reported worldwide, including 38 deaths. All cases remain associated (including indirect association following secondary person-to-person transmission in the UK, Italy, Tunisia and France) with transmission in the Middle East. The age of cases ranges from two years to 94 years (N=60 cases, information on age not available for four cases), with a median of 56 years. Overall 70% (43/61) of cases are males. [2] The reports of new infections in Saudi Arabia over the past few weeks indicate that there is an ongoing source of infection and low risk of transmission to humans in the Middle East. [3] The first French case raises the possibility that presentations may not initially include respiratory symptoms, especially in those with immunosuppression or underlying chronic conditions. This also needs to be taken into account when revising case detection strategies. [4] The confirmed infection in France of a patient who shared a hospital room with an index patient returning from the United Arab Emirates corroborates the risk of nosocomial transmission. The incubation period for this patient is calculated to have been 9�"�12 days, which is longer than previously estimated. One case in the Jordan cluster has an incubation period of 13 days. Therefore until further evidence emerges, the incubation period is being extended from 10 to 14 days, in accordance with the WHO decision. [5] These conclusions should be viewed in the light of the many uncertainties surrounding the investigation of cases in the Middle East. It is unusual to have such a degree of uncertainty at this stage in an outbreak."
European Centre for Disease Prevention and Control
2013-06-18
-
Pandemic Influenza Risk Management: WHO Interim Guidance
"Influenza pandemics are unpredictable but recurring events that can have consequences on human health and economic well-being worldwide. Advance planning and preparedness are critical to help mitigate the impact of a pandemic. This WHO [World Health Organization] guidance document, 'Pandemic Influenza Risk Management', updates and replaces 'Pandemic influenza preparedness and response: a WHO guidance document', which was published in 2009. This revision of the guidance takes account of lessons learnt from the influenza A(H1N1) 2009 pandemic and of other relevant developments. The influenza A(H1N1) 2009 pandemic was both the first of the 21st century and the first since WHO had produced pandemic preparedness guidance. The experience of Member States during the pandemic varied, yet several common factors emerged. Member States had prepared for a pandemic of high severity and appeared unable to adapt their national and subnational responses adequately to a more moderate event. Communications were also demonstrated to be of immense importance: the need to provide clear risk assessments to decision-makers placed significant strain on ministries of health; and effective communication with the public was challenging. […] This guidance can be used to inform and harmonize national and international pandemic preparedness and response. Countries should consider reviewing and/or updating national influenza preparedness and response plans to reflect the approach taken in this guidance. The roles and responsibilities of WHO relevant to pandemic preparedness, in terms of global leadership and support to Member States, are also articulated. This document is not intended to replace national plans, which should be developed by each country."
World Health Organization
2013-06-10
-
Seroepidemiological Investigation of Close Contacts of Novel Coronavirus (MERS-CoV) Patients
"A comprehensive assessment of all contacts -- including household, familial, social occupational and health care associated contacts -- of confirmed and probable MERS-CoV cases is warranted to determine the extent of (asymptomatic) infections, routes and risk of transmission, and guide efforts for prevention of (human to human) transmission of the MERS-CoV virus. This investigation outlines how to find and test all close contacts of laboratory confirmed and probable MERS-CoV patients. This protocol also outlines a case-control study and the epidemiological methods to guide data collection for the comprehensive assessment of the cases and controls to assess risk factors for MERS-CoV infection. […] This investigation will provide data to evaluate some of the key clinical, epidemiological, serological and virological characteristics of the first cases and their contacts to inform the development and updating of national and international policy and guidance to manage cases and reduce the spread and impact of infection. This investigation will also provide data to evaluate risk factors for infection."
Consortium for the Standardization of Influenza Seroepidemiology (CONSISE)
2013-06-06
-
Guidelines for Crisis Standards of Care During Disasters
From the Document: "The Institute of Medicine defined 'Crisis Standard of Care' (CSC) to be a 'substantial change in the usual health care operations and the level of care it is possible to deliver… justified by specific circumstances… and formally declared by a state government in recognition that crisis operations will be in effect for a sustained period.' Among various different terms used in different titles for this definition, the terms 'standard' and 'altered' are somewhat controversial, since there are an infinite number of catastrophic types and severities of disasters which may impact any given locality. Many such events are also unprecedented and have no 'standard' approach. Thus, our committee prefers to use the term 'crisis care.'"
American College of Emergency Physicians
Kaji, Amy; Hansoti, Bhakti; Boukhman, Milana
2013-06
-
Tools for Preparedness: Triage, Screening and Patient Management for Middle East Respiratory Syndryome Coronavirus (MERS-CoV) Infections in Acute Care Settings
This tool is intended to assist frontline health care workers (primarily in Emergency Departments, although the principles are applicable in other urgent care settings) in the identification and immediate management of patients who present with severe acute respiratory infection that may be due to Middle East Respiratory Syndrome coronavirus (MERS-CoV). This tool should be used in conjunction with guidance from the Ministry of Health and Long-Term Care (MOHLTC), available at: www.ontario.ca/novelcoronavirus."
Ontario Agency for Health Protection and Promotion
2013-06
-
Department and Agency Continuity Telework Exercise Exercise Plan (EXPLAN) Template
"This Exercise Plan (EXPLAN) template provides exercise planners with the information necessary for their participation in Continuity of Operations (COOP) Telework Exercise, referred to as DETERMINED SENTRY XX. This EXPLAN Template is a tool to assist agencies to conduct a telework exercise to determine current capabilities to operate in a telework or socially-distanced environment and to determine what needs to be done to enhance your current capabilities and to better prepare for a pandemic influenza or continuity event."
United States. Federal Emergency Management Agency
2013-05-31
-
Determined Sentry Continuity Telework Exercise Player Handbook Template
"This template is set up to provide an example of an exercise player handbook for use when conducting a telework exercise."
United States. Federal Emergency Management Agency
2013-05-31
-
Middle East Respiratory Syndrome - Coronavirus - Update [May 29, 2013]
"The Ministry of Health in Saudi Arabia has notified WHO [World Health Organization] of an additional five laboratory-confirmed cases with Middle East respiratory syndrome coronavirus (MERS-CoV). All five patients are from the Eastern region of the country, but not from Al-Ahsa, where an outbreak began in a health care facility in April 2013. The patients had underlying medical conditions which required multiple hospital visits. The government is conducting investigations into the likely source of infection in both the health care and the community settings. The first patient is a 56-year-old man with underlying medical conditions, who became ill on 12 May 2013 and died on 20 May 2013. The second patient is an 85-year-old woman with underling medical conditions who became ill on 17 May and is currently in critical condition. The third patient is a 76-year-old woman with underlying medical conditions who became ill on 24 May 2013 and was discharged from the hospital on 27 May 2013. The fourth patient is a 77-year-old man with underlying medical conditions who became ill on 19 May and died on 26 May 2013. The fifth patient is a 73-year-old man with underlying medical conditions who became ill on 18 May and died on 26 May 2013. Additionally, a patient earlier reported from Al-Ahsa, an 81-year-old woman has died. The government is continuing to investigate the outbreaks in the country. In France, the first laboratory-confirmed case in the country, with recent travel from the United Arab Emirates has died."
World Health Organization
2013-05-29
-
MMWR: Morbidity and Mortality Weekly Report, September 27, 2013
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). [It] is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. This issue of MMWR contains the following: "Deaths and Severe Adverse Events Associated with Anesthesia-Assisted Rapid Opioid Detoxification -- New York City, 2012"; "Influenza Vaccination Coverage Among Health-Care Personnel -- United States, 2012-13 Influenza Season"; "Influenza Vaccination Coverage Among Pregnant Women -- United States, 2012-13 Influenza Season"; "Updated Information on the Epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Guidance for the Public, Clinicians, and Public Health Authorities, 2012-2013"; "Progress in Increasing Electronic Reporting of Laboratory Results to Public Health Agencies -- United States, 2013"; "Notes from the Field: Department of Defense Response to a Multistate Outbreak of Fungal Meningitis -- United States, October 2012"; "Announcement: Final National and State-Level 2012-13 Influenza Vaccination Coverage Estimates Available Online"; and "QuickStats: Percentage of Emergency Department (ED) Visits That Were Dental-Related Among Persons Aged
Centers for Disease Control and Prevention (U.S.)
2013-05-24
-
Novel Coronavirus Summary and Literature Update - as of 17 May 2013
"Since April 2012, there have been 40 laboratory-confirmed cases of human infection with novel coronavirus (nCoV). Several countries in the Middle East have been affected, including Jordan, Saudi Arabia, the United Arab Emirates (UAE), and Qatar. Cases have also been reported by three countries in Europe: France, Germany, and the United Kingdom. All of the European cases have had a direct or indirect connection to the Middle East. However, in France and the United Kingdom, there has been limited local transmission among close contacts who had not been to the Middle East but had been in contact with a traveler recently returned from the Middle East. The most recent case reported had onset on 10 May 2013. Most patients are male (79%; 31 of 39 cases with sex reported), and range in age from 24 to 94 years (median 56 years). All of the laboratory confirmed cases had respiratory disease as part of the illness, and most had severe acute respiratory disease requiring hospitalization. Reported clinical features include acute respiratory distress syndrome (ARDS), renal failure requiring hemodialysis, consumptive coagulopathy, and pericarditis. Many patients have also had gastrointestinal symptoms including diarrhea during the course of their illness. One patient, who was immunocompromised, presented with fever, diarrhea and abdominal pain, but had no respiratory symptoms initially; pneumonia was identified incidentally on a radiograph. 20 of the 40 patients have died."
World Health Organization
2013-05-17
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV); Announcement of the Coronavirus Study Group
"During the summer of 2012, in Jeddah, Saudi Arabia a hitherto unknown coronavirus was
isolated from the sputum of a patient with acute pneumonia and renal failure. The isolate was provisionally called human coronavirus EMC. Shortly thereafter, September 2012, the same type of virus, named human coronavirus England 1, was recovered from a patient with severe respiratory illness, who had been transferred from the Gulf region of the Middle East to London, United Kingdom. The onset of the new disease was traced back to an even earlier time point. Already in April 2012, a cluster of pneumonia cases in health care workers occurred in an intensive care unit of a hospital in Zarqa, Jordan. Two persons died, both of which were confirmed to have been infected with the novel coronavirus through retrospective analysis of stored samples. These findings met with considerable concern. Although the number of cases documented is limited (thirty as of 6 May 2013), the morbidity and mortality of the infection is alarming, as is its uncanny resemblance -at least in its clinical features- to SARS [Severe Acute Respiratory Syndrome]. While a small minority of the known cases developed mild disease, most patients presented with a severe acute respiratory condition requiring hospitalization; the mortality rate is approximately 60%."
American Society for Microbiology
De Groot, Raoul J.; Baker, Susan C.; Baric, Ralph S. (Ralph Steven), 1954-
2013-05-15
-
Mining For Geographically Disperse Communities In Social Networks By Leveraging Distance Modularity
"Social networks where the actors occupy geospatial locations are prevalent in military, intelligence, and policing operations such as counter-terrorism, counter-insurgency, and combating organized crime. These networks are often derived from a variety of intelligence sources. The discovery of communities that are geographically disperse stems from the requirement to identify higher-level organizational structures, such as a logistics group that provides support to various geographically disperse terrorist cells. We apply a variant of Newman-Girvan modularity to this problem known as distance modularity. To address the problem of finding geographically disperse communities, we modify the well- known Louvain algorithm to find partitions of networks that provide near-optimal solutions to this quantity. We apply this algorithm to numerous samples from two real-world social networks and a terrorism network data set whose nodes have associated geospatial locations. Our experiments show this to be an effective approach and highlight various practical considerations when applying the algorithm to distance modularity maximization. Several military, intelligence, and law-enforcement organizations are working with us to further test and field software for this emerging application."
United States Military Academy
Shakarian, Paulo; Roos, Patrick; Callahan, Devon . . .
2013-05-13
-
Update of WHO Biosafety Risk Assessment and Guidelines for the Production and Quality Control of Human Influenza Vaccines Against Avian Influenza A(H7N9) Virus
"This document updates WHO [World Health Organization] guidance to national regulatory authorities and vaccine manufacturers on the safe production and quality control of human influenza vaccines produced in response to a pandemic threat1. It details international biosafety expectations for both pilot-scale and large-scale production, and quality control of vaccines against avian influenza A(H7N9) virus now causing human infections in China. The updated guidance applies to both candidate vaccine development and to production activities for inactivated and live attenuated influenza vaccines. The general guidance in this document should be supplemented by specific risk assessments that should be carried out by laboratories or manufacturers intending to work with H7N9 virus-derived candidate vaccine viruses (CVV) and are to be updated as new characteristics of the viruses become available."
World Health Organization
Engelhart, Othmar; Graham, Mary Louise; Grohmann, Gary
2013-05-10
-
Infection Prevention and Control During Health Care for Probable or Confirmed Cases of Novel Coronavirus (nCoV) Infection
"WHO [World Health Organization] has developed this interim guidance to meet the urgent need for up-to-date information and evidence-based recommendations for the safe care of patients with probable or confirmed novel coronavirus (nCoV) infection. The interim recommendations are informed by evidence-based guidelines WHO has published, including the 'Infection prevention and control of epidemic-and pandemic-prone acute respiratory diseases in health care. WHO Interim Guidelines'; recent systematic reviews, and review of current evidence on nCoV infection. The recommendations have been reviewed by members of the WHO Global Infection Prevention and Control Network (GIPCN) and other experts (see Acknowledgements for names and affiliations). These recommendations reflect current understanding of nCoV related to infection prevention and control (IPC) and they use interim case definitions. The guidance is intended for health-care workers (HCWs), health-care managers, and IPC teams. Specific WHO guidance on clinical management has already been published. WHO continues to monitor the situation closely for any changes that may affect the recommendations contained in this interim guidance. Should any factors change, WHO will issue a further update. Otherwise, this interim guidance document will expire 12 months after the date of publication. Links are given here to additional sources and evidence. If you have further questions, send an e-mail message to: outbreak@who.int, with 'Novel coronavirus IPC question' in the subject line. To date, there is very limited information on transmission and other features of nCoV based on the small number of cases reported so far globally. There is now clear evidence of limited, not sustained, human- to-human transmission, possibly involving different modes of transmission such as droplet and contact transmission, but further studies are required to better understand the risk of infection transmission."
World Health Organization
2013-05-06
-
Homeland Security: An Overall Strategy Is Needed to Strengthen Disease Surveillance in Livestock and Poultry, Report to Congressional Requesters
"International animal health authorities have stated that disease surveillance in livestock and poultry has as its main purpose the early detection of diseases and disease outbreaks. APHIS [Animal and Plant Health Inspection Service] has worked closely with states and industry over the past decades to eradicate diseases by, for example, providing states with funding and guidance. But the disease landscape has changed, with rapid global movement of humans and animals, creating new threats. GAO [Government Accountability Office] was asked to review federal animal disease surveillance efforts. This report examines (1) USDA's [U.S. Department of Agriculture] new approach to disease surveillance in light of a changing disease landscape and challenges, if any, the agency faces with this approach and (2) the extent to which this approach is guided by a strategy with measurable goals and supports broader national biosurveillance efforts. GAO reviewed relevant presidential directives, laws, regulations, guidance, policies, documents, and strategic plans related to disease surveillance in animals; visited swine facilities; and interviewed federal, state, and industry veterinarians and other officials. […] GAO recommends that as APHIS develops goals and measures for its new approach, it integrate the agency's vision into an overall strategy guiding how this approach supports national homeland security efforts to enhance the detection of biological threats. In their comments, USDA concurred with GAO's recommendation, and the Department of Homeland Security described its commitment to disease surveillance efforts."
United States. Government Accountability Office
2013-05
-
Pharmaceutical Resilience: Proceedings of the Workshop on Pharmaceutical Resilience for Serious Infectious Disease, 5 February 2013
From the forward: "In short, 'pharmaceutical resilience' is the principle of ensuring the public has access to appropriate medical pharmaceuticals when they are needed -- even in the face of strong factors that limit the supply of these products, potentially on a global scale. At present, pharmaceutical resilience is assured by stockpiling. Around the world, the typical government response to high-impact outbreaks of disease depends on ensuring that centrally‐held large stockpiles of appropriate drugs are maintained until they are required, then distributed to populations that need them. In some scenarios, such as pandemic influenza, this is based on a very large stockpile that can be distributed to the total population of an affected country. For other scenarios, such as a biological attack by terrorists, a smaller stockpile, perhaps based on the population size within a geographic area, might be adequate -- but these stocks would need to be made available to an at-risk population extremely rapidly."
Royal United Services Institute for Defence and Security Studies
Cole, Jennifer
2013-05
-
Practice Guidelines for Video-Based Online Mental Health Services
From the Scope: "The scope of these guidelines covers the provision of mental health services provided by a licensed healthcare professional when using real-time videoconferencing services transmitted via the Internet. Other certified professionals may take guidance from these guidelines, but the current version targets the practice of behavioral health by licensed healthcare professionals. The guidelines pertain to telemental health conducted between two parties, and do not address concerns related to multipoint videoconferencing. These guidelines include telemental health services when the initiating, receiving, or both sites are using a personal computer with a webcam or a mobile communications device (e.g., 'smart phone', laptop, or tablet) with two-way camera capability. These guidelines do not address communications between professionals and clients or patients via texting, e-mail, chatting, social network sites, online 'coaching' or other non-mental health services."
American Telemedicine Association
2013-05
-
Top 10 Influenza Pandemic Response Planning Tips for Senior Public Health Officials
"CDC [Centers for Disease Control and Prevention] is closely monitoring the avian influenza A (H7N9) situation in China and is taking several preparedness measures. While no H7N9 cases have been detected in the United States or anywhere outside of China at this time and there is no evidence of sustained human-to-human transmission, CDC encourages state and local public health agencies to use this time to review and reinforce their pandemic preparedness plans in case the situation escalates. CDC has developed these Top 10 Influenza Pandemic Response Planning Tips to help senior public health officials at the state, local, tribal, and territorial levels identify the most critical capabilities and activities needed to assure jurisdictional readiness for an influenza pandemic response. These suggestions are designed to help jurisdictions identify remaining influenza pandemic preparedness operational gaps and improve readiness for potential response. This is not an exhaustive list of all the steps necessary for a sustained influenza pandemic response, but it is intended to give senior public health officials a quick guide for accelerated planning. CDC recommends jurisdictions review their respective H1N1 after-action reports and other relevant data to better assess operational requirements."
Centers for Disease Control and Prevention (U.S.); United States. Department of Health and Human Services
2013-05
-
Diagnostic Preparedness in Europe for Detection of Avian Influenza A(H7N9) Viruses
"In China, a novel avian-origin reassortant influenza A(H7N9) virus has been detected in a number of human cases. In response to the potential cross-border health threat associated with emerging disease caused by the appearance of the novel virus, European laboratories need to be aware of the novel virus and adapt and confirm their diagnostic capability to detect and identify it. This document is a joint CNRL/ECDC/WHO [Community Network of Reference Laboratories for Human Influenza in Europe/European Centre for Disease Prevention and Control/World Health Organization] Europe technical briefing note for virology laboratories. It is designed to assist clinical and public health laboratory directors in appraising options for establishing novel diagnostic assays for screening and confirming cases of infection in humans. This document is intended for use in the area of human influenza surveillance, investigation, risk assessment, and control, encouraging cooperation between expert and reference laboratories in order to 'foster the development of sufficient capacity within the Community for the diagnosis, detection, identification and characterisation of infectious agents which may threaten public health'."
Community Network of Reference Laboratories for Human Influenza in Europe; World Health Organization. Regional Office for Europe; European Centre for Disease Prevention and Control
Hungnes, Olav; Ellis, Joanna; Ziegler, Thedi . . .
2013-04-23
-
Tracking Anti Vaccination Sentiment in Eastern European Social Media Networks
From the Summary: "This UNICEF [United Nations Children's Fund] working paper aims to track and analyse online anti-vaccination sentiment in social media networks by examining conversations across social media in English, Russian, Romanian and Polish. The findings support the assumption that parents actively use social networks and blogs to inform their decisions on vaccinating their children. The paper proposes a research model that detects and clusters commonly-used keywords and intensity of user interaction. The end goal is the development of targeted and efficient engagement strategies for health and communication experts in the field as well as for partner organisations."
UNICEF
Majewski, Sebastian; Beger, Gerrit
2013-04
-
Interim Surveillance Recommendations for Human Infection with Novel Coronavirus
"This document provides updated surveillance guidance for novel coronavirus (nCoV). WHO [World Health Organization] will continue to update these recommendations as more information becomes available. Current numbers and descriptions of reported cases are found on the main WHO novel coronavirus page. The primary changes included in this revision are: [1] Addition of a recommendation to test individuals with unusually severe respiratory disease even in the presence of another aetiology if the other agent does not fully explain the patient's illness. [2] Specific revised recommendations for countries where the novel corona virus has been detected. [3] Recommendations for investigations and studies to be carried out where cases are detected, which may help describe critical clinical and epidemiological features of the virus."
World Health Organization
2013-03-18
-
EMR-ISAC: InfoGram, Volume 13 Issue 11 [March 14, 2013]
This edition of the Emergency Management and Response Information Sharing and Analysis Center's "Infogram" contains the following articles: "Free All-Hazards Training
for Rural Departments," "State and Local Law Enforcement Resources," "Wildland Fire Regional Action Plans Submitted," and "CDC [Centers for Disease Control and Prevention] Issues Health Advisory for Coronavirus."
Emergency Management and Response-Information Sharing and Analysis Center (U.S.)
2013-03-14
-
Public Law 113-5: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
Public Law 113-5 is "[an] Act to reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, and for other purposes."
United States. Government Printing Office
2013-03-13
